RIVASTIGMINE-DRLA rivastigmine (as hydrogen tartrate) 3 mg capsule blister pack

Страна: Австралия

Язык: английский

Источник: Department of Health (Therapeutic Goods Administration)

Активный ингредиент:

rivastigmine hydrogen tartrate, Quantity: 4.8 mg (Equivalent: rivastigmine, Qty 3 mg)

Доступна с:

Dr Reddys Laboratories Australia Pty Ltd

ИНН (Международная Имя):

rivastigmine hydrogen tartrate

Фармацевтическая форма:

Capsule, hard

состав:

Excipient Ingredients: microcrystalline cellulose; colloidal anhydrous silica; titanium dioxide; hypromellose; iron oxide yellow; sodium lauryl sulfate; sunset yellow FCF; magnesium stearate; Gelatin; brilliant scarlet 4R; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; Shellac; allura red AC; povidone; sodium hydroxide

Администрация маршрут:

Oral

Штук в упаковке:

112, 56, 14, 28

Тип рецепта:

(S4) Prescription Only Medicine

Терапевтические показания :

RIVASTIGMINE is indicated for the treatment of patients with mild to moderately severe dementia of the Alzheimer's type.

Обзор продуктов:

Visual Identification: White to off-white powder filled in size 2 hard gelatin capsules, light orange opaque colour cap, light orange opaque colour body, imprinted with 'RV' over '3' on body with red ink; Container Type: Blister Pack; Container Material: PVC/PVDC/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Статус Авторизация:

Licence status A

Дата Авторизация:

2012-09-24